1Brenner H, Engelsrnann B, Stegraier C, et al. Clinical epidemiology of bilateral breast cancer[ J]. Cancer, 1993,72:3625 - 3629.
2Awad AT, Husseini G, Anwar M, et al. Bilaternal primary breast cancer,a clinicpathological study of the second primary[ J]. Int Surg, 1996,81 ( 1 ) :57 - 60.
1Ozer E, Canda T, Kuyucuodlu F. p53 mutations in bilateral breast carcinoma. Correlation with Ki-67 expression and the mean nuclear volume[J]. Cancer lett, 1998, 122(1-2): 101-106.
2Rovatti M, G erosa E, Turi V, et al. Multiple primary malignant neoplasms[J]. Minerva Chirurgica, 1995, 50(11): 949-958.
4Brenner H, Engelsrnann B, Stegrnaier C, et al. Clinical epidemiology of bilateral breast canaer[J]. Cancer, 1993, 72: 3629-3635.
5Awad AT, Husseini G, Anwar M, et al. Bilateral primary breastcancer; a clinicpathological study of the second primary[J]. Int Surg, 1996, 81(1): 57-60.
6Suris-Swartz PJ, Schillkraut JM, Vinve MF, et al. Age at dignosis and multiple primary cancer of the breast and ovary [J]. Breast Cancer RES Treat, 1996, 41(1): 21-29.
7Rutguist LE, Cedermark B, Glas U,et al. Contralateral primary tumor in breast cancer patients in a randomized trial of adjuvant Tamoxifen therapy[J]. J Natl Cancer In st, 1991, 83(18):1299-1306.
8Kinoshita T, Ueda M,Enomoto K, et al. Comparison of p53 gene abnormalities in bilateral and unilateral breast cancer[J]. Cancer, 1995, 76(12): 2504-2509.
9Tuck AB, O'Maaey FP, Singhal H, et al. Osteoponyin and p53 expression are associated with tumor progression in a case synchronous, bilateral,invasive mammary carcinoma[J]. Arch Pathol Lab Med, 1997, 121(6): 578-584.
10Ssarela AO, Risanen TJ, Kiviniemi HO, et al. Mammographic and uhrosonographic findings in bilayeral breast cancer, a comparative study[J]. Eur Radiol, 1998, 8(4): 634-638.
